The A3 Adenosine Receptor as a New Target for Cancer Therapy and Chemoprotection

By Fishman P.   Bar-Yehuda S.   Barer F.   Madi L.   Multani A.S.   Pathak S.  

Experimental Cell Research, Vol. 269, Iss. 2, 2001-10 ,pp. : 230-236

Elsevier

Access to resources Recommend Favorite

CCN1 promotes vascular endothelial growth factor secretion through α_vβ₃ integrin receptors in breast cancer

By Espinoza Ingrid   Menendez Javier   KVP Chandra   Lupu Ruth  

Journal of Cell Communication and Signaling, Vol. 8, Iss. 1, 2014-03 ,pp. : 23-27

Springer Publishing Company

Access to resources Recommend Favorite

CCN1: a novel target for pancreatic cancer

By Leask Andrew  

Journal of Cell Communication and Signaling, Vol. 5, Iss. 2, 2011-06 ,pp. : 123-124

Springer Publishing Company

Access to resources Recommend Favorite

CCN2: a bona fide target for anti-fibrotic drug intervention

By Leask Andrew  

Journal of Cell Communication and Signaling, Vol. 5, Iss. 2, 2011-06 ,pp. : 131-133

Springer Publishing Company

Access to resources Recommend Favorite

Il-6 Polymorphism, Anti-Il-6 Therapy and Animal Models of Multiple Myeloma

By Jeffery R.   Mitchison N.A.  

Cytokine, Vol. 16, Iss. 3, 2001-11 ,pp. : 87-87

Academic Press

Access to resources Recommend Favorite